- Home
- Publications
- Publication Search
- Publication Details
Title
TDO as a therapeutic target in brain diseases
Authors
Keywords
TDO, Tryptophan metabolism, Schizophrenia, Alzheimer’s disease, Glioma
Journal
METABOLIC BRAIN DISEASE
Volume 31, Issue 4, Pages 737-747
Publisher
Springer Nature
Online
2016-04-14
DOI
10.1007/s11011-016-9824-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour
- (2014) Sinead M. Gibney et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
- (2014) Seray Adams et al. PLoS One
- Structural and functional analyses of human tryptophan 2,3-dioxygenase
- (2014) Bing Meng et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Molecular Basis of Etiological Implications in Alzheimer’s Disease: Focus on Neuroinflammation
- (2013) Rituraj Niranjan MOLECULAR NEUROBIOLOGY
- Is T-helper type 2 shift schizophrenia-specific? Primary results from a comparison of related psychiatric disorders and healthy controls
- (2013) Sonnig Sue-Whei Chiang et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease
- (2012) Mohamad A. Alsadany et al. American Journal of Alzheimers Disease and Other Dementias
- Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
- (2012) Marisa Möller et al. BRAIN BEHAVIOR AND IMMUNITY
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation
- (2012) A. T. van der Goot et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia
- (2012) Thomas L. Schwartz et al. Frontiers in Pharmacology
- Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
- (2011) Ikwunga Wonodi ARCHIVES OF GENERAL PSYCHIATRY
- Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
- (2011) A.M. Myint et al. BRAIN BEHAVIOR AND IMMUNITY
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy
- (2011) Suvi Liimatainen et al. EPILEPSY RESEARCH
- Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators
- (2011) Eduard Dolušić et al. JOURNAL OF MEDICINAL CHEMISTRY
- Behavioural studies with a newly developed neuroprotective KYNA-amide
- (2011) Levente Gellért et al. JOURNAL OF NEURAL TRANSMISSION
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders
- (2010) Gregory F. Oxenkrug JOURNAL OF NEURAL TRANSMISSION
- Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease
- (2010) David J. Bonda et al. REDOX REPORT
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
- (2010) K. R. Linderholm et al. SCHIZOPHRENIA BULLETIN
- Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium
- (2009) Christian Betzen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington’s disease
- (2009) Caroline M. Forrest et al. JOURNAL OF NEUROCHEMISTRY
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
- (2009) Abdur Rahman et al. PLoS One
- Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder
- (2009) Christine L. Miller et al. SCHIZOPHRENIA RESEARCH
- Exploring the mechanism of tryptophan 2,3-dioxygenase
- (2008) Sarah J. Thackray et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Effects of the kynurenine 3-hydroxylase inhibitor Ro 61-8048 after intrastriatal injections on the severity of dystonia in the dtsz mutant
- (2008) Melanie Hamann et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder
- (2008) Christine L. Miller et al. NEUROCHEMISTRY INTERNATIONAL
- Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum
- (2008) L. Amori et al. NEUROSCIENCE
- Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
- (2007) Leonel E. Rojo et al. ARCHIVES OF MEDICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search